How much funding has Simtra BioPharma Solutions raised?

Simtra BioPharma Solutions has raised $4.3B in total funding, most recently a Private Equity round.

Who are Simtra BioPharma Solutions's investors?

Simtra BioPharma Solutions's investors include Advent International, Warburg Pincus.

When was Simtra BioPharma Solutions founded?

Simtra BioPharma Solutions was founded in 2022.

Where is Simtra BioPharma Solutions headquartered?

Simtra BioPharma Solutions is headquartered in Bloomington, Indiana, United States.

What industry is Simtra BioPharma Solutions in?

Simtra BioPharma Solutions operates in Biotech, Contract Manufacturing.

How many employees does Simtra BioPharma Solutions have?

Simtra BioPharma Solutions has 1001-5000 employees.

Simtra BioPharma Solutions

The premier CDMO for sterile injectable pharmaceuticals

Bloomington, United States · Founded 2022 · $4.3B raised

Biotech

Contract Manufacturing

Headquarters: Bloomington, Indiana
Employees: 1001–5000
Founded: 2022
Business Model: B2B

Website: simtra.com
Total Funding: $4.3B
Last Round: $4.3B Private EquityOct 2023
Rounds: 1

About

Simtra BioPharma Solutions is a premier independently owned CDMO with over 65 years of sterile injectable manufacturing expertise, spun out of Baxter International in 2022. It operates cGMP-compliant ISO 14001-certified facilities in Bloomington, Indiana and Halle/Westfalen, Germany, providing formulation development, lyophilization, fill/finish, and regulatory support for vials and prefilled syringes. Simtra is investing $250M+ to expand its Bloomington campus.

Summary

Simtra BioPharma Solutions is a Biotech company based in Bloomington, United States, founded in 2022. It has raised $4.3B in total across 1 round, most recently a $4.3B Private Equity round in Oct 2023. Investors include Advent International and Warburg Pincus.